The expression analysis (Fig. 2) revealed that GAS5 levels are significantly downregulated (p = 0.001) in bladder tumours compared to the matched adjacent normal specimens in 67.4% of the screened patients (Fig. 2a). The gene discussed is GAS5; the disease is urinary bladder neoplasm.